| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Wanbangde Pharmaceutical Holding Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.04 |
| 52 Week High | CN¥7.42 |
| 52 Week Low | CN¥3.70 |
| Beta | 0.72 |
| 11 Month Change | 25.37% |
| 3 Month Change | 18.59% |
| 1 Year Change | -23.64% |
| 33 Year Change | -50.20% |
| 5 Year Change | -41.46% |
| Change since IPO | 23.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002082 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 9.6% | 1.6% | 2.7% |
| 1Y | -23.6% | 0.7% | 4.6% |
Return vs Industry: 002082 underperformed the CN Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: 002082 underperformed the CN Market which returned 4.6% over the past year.
Price Volatility
| 002082 volatility | |
|---|---|
| 002082 Average Weekly Movement | 6.3% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 7.6% |
| 10% most volatile stocks in CN Market | 11.5% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 002082 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002082's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 1,605 | Shouming Zhao | www.wepon.com.cn |
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through Pharmaceutical Production and Sales, and Medical Equipment and Personal Equipment Production and Sale segments.
Wanbangde Pharmaceutical Holding Group Co., Ltd. Fundamentals Summary
| 002082 fundamental statistics | |
|---|---|
| Market cap | CN¥3.08b |
| Earnings (TTM) | CN¥55.32m |
| Revenue (TTM) | CN¥1.56b |
55.7x
P/E Ratio2.0x
P/S RatioIs 002082 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002082 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.56b |
| Cost of Revenue | CN¥943.83m |
| Gross Profit | CN¥612.35m |
| Other Expenses | CN¥557.02m |
| Earnings | CN¥55.32m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 30, 2024
| Earnings per share (EPS) | 0.09 |
| Gross Margin | 39.35% |
| Net Profit Margin | 3.56% |
| Debt/Equity Ratio | 33.4% |
How did 002082 perform over the long term?
See historical performance and comparison